TRAP-6
Based on 6 publication(s) in Google Scholar
TRAP-6 (PAR-1 agonist peptide), a peptide fragment, is a selective protease activating receptor 1 (PAR1) agonist. TRAP-6 activates human platelets via the thrombin receptor. TRAP-6 shows no activity at PAR4.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.98%
- CAS No.: 141136-83-6
- Formule: C34H56N10O9
- Masse moléculaire:748.87
-
Stockage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-P1309
PAR-4 Agonist Peptide, amide
-
HY-10119
Vorapaxar
-
HY-P0283
Protease-Activated Receptor-2, amide
-
HY-P1308
SLIGRL-NH2
-
HY-13965
Parmodulin 2
-
HY-P1309A
PAR-4 Agonist Peptide, amide TFA
-
HY-13757A
Tamoxifen
-
HY-12290
Arg-Gly-Asp-Ser
-
HY-W010918
Adenosine 5'-diphosphate
-
HY-P0226
TFLLR-NH2
-
HY-P0226A
TFLLR-NH2TFA
-
HY-15371
Forskolin
Publications Citing Use of MedChemExpress (MCE) TRAP-6
More- Phytomedicine. 2025 Jun:141:156736. [Abstract]
- Phytomedicine. 2022 Sep:104:154271. [Abstract]
- J Thromb Haemost. 2025 Mar 26:S1538-7836(25)00200-4. [Abstract]
- J Thromb Haemost. 2024 May;22(5):1463-1474. [Abstract]
- Mol Med Rep. 2019 Jun;19(6):5291-5300. [Abstract]
- Thromb Res. 2024 Feb:234:39-50. [Abstract]
Customer Validation & Images
-
ELISA
-
IF
-
ELISA
-
Bio/Physico-chemical Assay
-
WB
Activité biologique
|
PAR1 96 nM (IC50) |
PAR1 |
TRAP-6 (0.01-10 μM) triggers calcium mobilization in Xenopus oocytes heterologously expressing PAR1[1].
TRAP-6 (0.01-10 μM; 30 min) activates human platelets[1].
TRAP-6 (100 μM) does not cause the platelets of rabbits or rats to change shape, aggregate, release granule contents, or form thromboxane[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 141136-83-6
-
Appearance Solid
-
Masse moléculaire 748.87
-
Formule C34H56N10O9
-
Color White to off-white
-
Synonyms
PAR-1 agonist peptide; Thrombin Receptor Activator Peptide 6
-
Sequence
Ser-Phe-Leu-Leu-Arg-Asn
-
Sequence Shortening
SFLLRN
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Phytomedicine
Formononetin attenuates myocardial ischemia/reperfusion injury by regulating neutrophil extracellular traps formation and platelet activation via platelet CD36. [Abstract]2025 Jun:141:156736. PMID: 40250000
TRAP-6 purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2025 Jun:141:156736. [Abstract]
Trap-6 (25 μM) significantly increased the degree of platelet activation.
TRAP-6 purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2025 Jun:141:156736. [Abstract]
Immunofluorescence of platelets and neutrophil extracellular traps (NETs) (MPO, CitH3) (scale bar, 40 μm, n = 3). The results showed that significant NETs formation was observed in both the C+Trap-6 (25 μM) group and the C+Trap-6+FMN+CD36 group. #p < 0.05 vs Sham group; ##p < 0.01 vs Sham group; ###p < 0.001 vs Sham group; *p < 0.05 vs MI/R group, **p < 0.01 vs MI/R group, ***p < 0.001 vs MI/R group; $p < 0.05 vs C+Trap-6+FMN group; $$$p < 0.001 vs C+Trap-6+FMN group.
-
Phytomedicine
Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk. [Abstract]2022 Sep:104:154271. PMID: 35777120
TRAP-6 purchased from MedChemExpress. Usage Cited in: Phytomedicine. 2022 Sep:104:154271. [Abstract]
Influence of DSS on aggregation of platelets induced by TRAP-6 (2 μM). n = 3.
-
J Thromb Haemost
Maternal platelet-derived factors induce trophoblastic LAIR2 expression to promote trophoblast invasion and inhibit platelet activation at the fetal-maternal interface. [Abstract]2025 Mar 26:S1538-7836(25)00200-4. PMID: 40154792
TRAP-6 purchased from MedChemExpress. Usage Cited in: J Thromb Haemost. 2025 Mar 26:S1538-7836(25)00200-4. [Abstract]
To test the effect of LAIR2 on collagen-induced platelet activation, platelets from pregnant women were stimulated with either collagen type I (COL1) or TRAP6, which were either preincubated with or without rhLAIR2 (G). Subsequent aggregometry showed that preincubation with LAIR2 inhibited platelet activation induced by COL1 but not TRAP-6 (50 μM; 30 min)(H).
-
J Thromb Haemost
Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity. [Abstract]2024 May;22(5):1463-1474. PMID: 38266680 -
Mol Med Rep
Vorapaxar stabilizes permeability of the endothelial barrier under cholesterol stimulation via the AKT/JNK and NF‑κB signaling pathways. [Abstract]2019 Jun;19(6):5291-5300. PMID: 31059055
TRAP-6 purchased from MedChemExpress. Usage Cited in: Mol Med Rep. 2019 Jun;19(6):5291-5300. [Abstract]
Detection of expression levels of p‑AKT, AKT, p‑JNK, JNK and NF‑κB using western blotting. Groups: NC, negative control group; CH, a cholesterol stimulation group; CH+T, cholesterol stimulation with TRAP‑6 treatment group; CH+V, cholesterol stimulation with vorapaxar treatment group.
-
Thromb Res
2024 Feb:234:39-50. PMID: 38159323
Solvant et solubilité
H2O : 25 mg/mL (33.38 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (278 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Kahn ML, et, al. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999 Mar;103(6):879-87. [Content Brief]
[2]. Kinlough-Rathbone RL, et, al. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood. 1993 Jul 1;82(1):103-6. [Content Brief]
[3]. Chintala MS, et, al. Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats. Eur J Pharmacol. 1998 May 22;349(2-3):237-43. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.3353 mL | 6.6767 mL | 13.3535 mL | 33.3836 mL |
| 5 mM | 0.2671 mL | 1.3353 mL | 2.6707 mL | 6.6767 mL | |
| 10 mM | 0.1335 mL | 0.6677 mL | 1.3353 mL | 3.3384 mL | |
| 15 mM | 0.0890 mL | 0.4451 mL | 0.8902 mL | 2.2256 mL | |
| 20 mM | 0.0668 mL | 0.3338 mL | 0.6677 mL | 1.6692 mL | |
| 25 mM | 0.0534 mL | 0.2671 mL | 0.5341 mL | 1.3353 mL | |
| 30 mM | 0.0445 mL | 0.2226 mL | 0.4451 mL | 1.1128 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
TRAP-6 Related Classifications
HY-P0078 Related Classifications
Powered by Bioz
- TRAP-6
- 141136-83-6
- PAR-1 agonist peptide
- Thrombin Receptor Activator Peptide 6
- TRAP6
- TRAP 6
- Thrombin Receptor Activator Peptide6
- Thrombin Receptor Activator Peptide 6
- Thrombin Receptor Activator Peptide-6
- Protease Activated Receptor (PAR)
- protease
- activating
- receptor
- PAR1
- platelets
- thrombin
- Inhibitor
- inhibitor
- inhibit